PT-141 (Bremelanotide): Research Applications and Quality Assessment

PT-141 (Bremelanotide): Research Applications and Quality Assessment

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist primarily researched for its potential effects on sexual dysfunction. Unlike other treatments that act on the vascular system, PT-141 directly influences the nervous system to modulate sexual arousal. This article provides a comprehensive overview of PT-141, focusing on its molecular structure, mechanism of action, research applications, crucial quality markers, potential impurities, and recommended storage conditions. This information is intended to assist researchers in evaluating and sourcing high-quality PT-141 for their studies.

Molecular Structure and Properties

Bremelanotide is a cyclic heptapeptide with the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Gly]-NH2. Its molecular formula is C₅₀H₆₈N₁₄O₁₀, and its molecular weight is approximately 1025.2 Da. The cyclic structure is crucial for its receptor binding affinity and selectivity. The presence of non-natural amino acids, such as norleucine (Nle) and D-phenylalanine (D-Phe), contributes to its stability and resistance to enzymatic degradation.

Key structural features:

• Cyclic heptapeptide
• Non-natural amino acids (Nle, D-Phe) for enhanced stability
• Acetylated N-terminus
• Amidated C-terminus

Mechanism of Action

PT-141 exerts its effects by binding to melanocortin receptors, primarily MC1R and MC4R. While MC1R is mainly associated with pigmentation, MC4R plays a significant role in sexual function, appetite, and energy homeostasis. By activating MC4R in the central nervous system, PT-141 modulates neuronal pathways involved in sexual arousal. Specifically, it influences the release of dopamine and other neurotransmitters that promote sexual desire and excitement. Unlike PDE5 inhibitors like sildenafil (Viagra), PT-141 does not directly affect blood flow but rather acts directly on the brain.

The binding affinities of PT-141 to different melanocortin receptors vary. Typically, it exhibits a higher affinity for MC4R compared to other subtypes, contributing to its relatively selective action on sexual function. Studies have reported Ki values (dissociation constant) for PT-141 at MC4R in the range of 10-50 nM.

Research Applications

PT-141 has been extensively studied in preclinical and clinical settings for the treatment of sexual dysfunction, particularly hypoactive sexual desire disorder (HSDD) in women and erectile dysfunction (ED) in men. Research areas include:

• Hypoactive Sexual Desire Disorder (HSDD): Clinical trials have demonstrated the efficacy of PT-141 in increasing sexual desire and reducing distress associated with low sexual desire in premenopausal women.
• Erectile Dysfunction (ED): Studies have shown that PT-141 can improve erectile function in men with ED, particularly in those who do not respond well to PDE5 inhibitors.
• Melanocortin Receptor Research: PT-141 serves as a valuable tool for investigating the roles of melanocortin receptors in various physiological processes beyond sexual function, such as inflammation and energy balance.
• Central Nervous System Effects: Researchers are exploring the potential of PT-141 to modulate mood and cognitive function through its actions on melanocortin receptors in the brain.

Quality Markers for PT-141

Ensuring the quality of PT-141 is paramount for reliable research outcomes. Several key quality markers should be assessed when evaluating peptide products:

1. Peptide Purity

Purity refers to the percentage of the desired peptide in the product relative to other organic impurities. High purity is essential to minimize the risk of off-target effects and ensure accurate dose-response relationships. The generally accepted minimum purity for research-grade peptides is 95%, although higher purities (e.g., >98%) are preferred for critical applications. Purity is typically determined by Reverse Phase High-Performance Liquid Chromatography (RP-HPLC).

Practical Tip: Request a chromatogram from the supplier to visually inspect the purity profile. Look for a single, sharp peak corresponding to PT-141.

2. Peptide Identity

Verifying the identity of the peptide confirms that the product is indeed PT-141 and not a different peptide or a mixture of peptides. Mass spectrometry (MS) is the gold standard for identity confirmation. The measured molecular weight should match the theoretical molecular weight of PT-141 (1025.2 Da) within a reasonable tolerance (e.g., ± 0.5 Da). Amino acid analysis can also be used, but it is less specific than MS.

Practical Tip: Always request mass spectrometry data from the supplier. Check for the correct molecular ion peak [M+H]+ or [M+2H]2+.

3. Peptide Content

Peptide content refers to the actual amount of peptide present in the product, taking into account factors such as residual water and counterions (e.g., acetate). Peptide content is typically expressed as a percentage. Ideally, the peptide content should be close to 100%, but values between 70% and 90% are commonly observed for peptides obtained by solid phase peptide synthesis (SPPS). Quantitative amino acid analysis or elemental analysis can be used to determine peptide content.

Practical Tip: Be aware that a product with 98% purity may still have a lower peptide content due to the presence of water or counterions. Ask the supplier for the peptide content value in addition to the purity.

4. Water Content

Peptides are hygroscopic and can absorb water from the atmosphere. Excessive water content can affect the accuracy of dosing and stability of the peptide. The water content should be minimized and typically kept below 5% using techniques such as Karl Fischer titration.

5. Counterion Content

During peptide synthesis and purification, counterions (e.g., acetate, trifluoroacetate) are often introduced to neutralize the peptide's charge. The type and amount of counterion can influence the peptide's solubility and stability. Trifluoroacetate (TFA) is a common counterion but can be problematic for some applications due to its potential toxicity. Acetate is generally preferred. Ion chromatography can be used to determine counterion content.

6. Amino Acid Composition

Amino acid analysis confirms the presence and correct ratio of amino acids in the peptide sequence. This is particularly important for complex peptides or those containing modified amino acids. Deviations from the expected amino acid composition can indicate synthesis errors or degradation.

7. Endotoxin Levels

Endotoxins, such as lipopolysaccharides (LPS), are bacterial toxins that can contaminate peptide products, particularly those produced in bacterial expression systems. Even trace amounts of endotoxins can elicit strong immune responses and confound experimental results. Endotoxin levels should be minimized, especially for in vivo studies. The Limulus Amebocyte Lysate (LAL) assay is commonly used to detect and quantify endotoxins. Acceptable endotoxin levels depend on the application, but typically should be below 10 EU/mg for in vitro studies and below 1 EU/mg for in vivo studies.

8. Solubility

The solubility of PT-141 in relevant solvents (e.g., water, saline, DMSO) should be assessed to ensure that it can be easily dissolved and administered. Poor solubility can lead to inaccurate dosing and inconsistent results. The supplier should provide information on recommended solvents and solubility limits.

Common Impurities

PT-141, like other synthetic peptides, can contain various impurities arising from the synthesis process. Common impurities include:

• Truncated Sequences: Peptides missing one or more amino acids due to incomplete coupling during synthesis.
• Deletion Sequences: Peptides with one or more amino acids deleted from the intended sequence due to coupling failures.
• Modified Amino Acids: Peptides containing incorrectly modified amino acids (e.g., incomplete deprotection).
• Diastereomers: Peptides containing incorrect stereoisomers of amino acids.
• Protecting Groups: Residual protecting groups that were not completely removed during deprotection steps.
• Solvents and Reagents: Traces of solvents and reagents used during synthesis and purification.
• Counterions: Excess counterions (e.g., acetate, TFA).

High-quality peptide synthesis and purification processes aim to minimize these impurities. RP-HPLC and MS are crucial for detecting and quantifying impurities. Suppliers should provide detailed information on the purification methods used and the levels of detectable impurities.

Storage Requirements

Proper storage is essential to maintain the stability and integrity of PT-141. The following storage conditions are recommended:

• Temperature: Store lyophilized PT-141 at -20°C or -80°C for long-term storage. Avoid repeated freeze-thaw cycles.
• Desiccation: Store the peptide in a tightly sealed container with a desiccant to minimize moisture absorption.
• Light Protection: Protect the peptide from direct light exposure, as light can promote degradation.
• Solution Storage: If the peptide is reconstituted in solution, store it at 2-8°C for short-term use (e.g., days to weeks). For longer storage of solutions, aliquot and freeze at -20°C or -80°C.
• Solvent Compatibility: When reconstituting the peptide, use a compatible solvent such as sterile water, saline, or DMSO. Avoid using solvents that can react with the peptide or promote degradation.

Practical Tip: Aliquot reconstituted PT-141 into single-use vials to avoid repeated freeze-thaw cycles, which can degrade the peptide.

Sourcing Considerations

Selecting a reputable supplier is critical for obtaining high-quality PT-141. Consider the following factors when sourcing peptides:

• Supplier Reputation: Choose a supplier with a proven track record of providing high-quality peptides and excellent customer service. Check for customer reviews and testimonials.
• Quality Control Procedures: Inquire about the supplier's quality control procedures, including the analytical methods used to assess purity, identity, and peptide content.
• Certificates of Analysis (COAs): Request a COA for each batch of peptide, which should include detailed information on the quality markers discussed above.
• Manufacturing Practices: Ensure that the supplier follows Good Manufacturing Practices (GMP) or similar quality standards.
• Price: While price is a factor, prioritize quality over cost. Extremely low prices may indicate compromised quality.
• Customer Support: Choose a supplier that offers responsive and knowledgeable customer support to address any questions or concerns.

Key Takeaways

• PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist primarily researched for sexual dysfunction.
• Its mechanism of action involves activating MC4R in the central nervous system, modulating neuronal pathways related to sexual arousal.
• Key quality markers to assess include peptide purity (?95% by HPLC), identity (confirmed by mass spectrometry), peptide content, water content (?5%), and endotoxin levels (?1 EU/mg for in vivo studies).
• Common impurities include truncated sequences, deletion sequences, and residual solvents.
• Proper storage is crucial: store lyophilized PT-141 at -20°C or -80°C in a desiccated, light-protected environment. Avoid repeated freeze-thaw cycles.
• Select a reputable supplier with robust quality control procedures and comprehensive Certificates of Analysis.